Lilly CEO says company opposes codification of Trump drug pricing deals
Source: SeekingAlpha
2026-04-01 17:16:17 ET
More on Eli Lilly
- Eli Lilly's Centessa Deal Shows It Is Awake To New Narcolepsy Reality
- Novo Nordisk Vs. Eli Lilly: Cheap Vs. Expensive, But No Clear Opportunity
- Why Eli Lilly Remains My Top Obesity Bet
- Lilly CEO says new GLP-1 pill's scalability will help expand global reach
- Eli Lilly gains approval of weight loss pill orforglipron
Read the full article on Seeking Alpha
For further details see:
Lilly CEO says company opposes codification of Trump drug pricing deals
Novartis AG
NASDAQ: NVS
NVS Trading
-0.26% G/L:
$150.47 Last:
852,043 Volume:
$151.84 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
